Peer Exchange


Redefining Treatment Outcomes in Dravet Syndrome

June 7th 2021

Panelists discuss recommendations for the diagnosis, treatment, and management of patients with Dravet Syndrome.

Strategies in Treating Relapsing-Remitting Multiple Sclerosis

April 19th 2021

Recommendations for appropriate treatment selection and use of high efficacy therapies as treatment for relapsing-remitting multiple sclerosis.

The Changing Landscape in the Treatment of Spinal Muscular Atrophy

April 16th 2021

Crystal Proud, MD; Claudia Chiriboga, MD, MPH; Tom Crawford, MD; Basil Darras, MD; and Carolina Tesi Rocha, MD provide a discussion on the importance of early diagnosis and treatment of spinal muscular atrophy and consider data from recent clinical trials of disease-modifying therapy options.

Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)

April 13th 2021

Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results.

Management of Progressive Multiple Sclerosis

March 18th 2021

Experts discuss the diagnosis and treatment of progressive multiple sclerosis.

Recent Advances in the Treatment of Hereditary ATTR Amyloidosis (hATTR)

March 12th 2021

Key insight into treating ATTR Amyloidosis, including the use of new therapeutic options to provide a practical perspective on how recent data may apply to your clinical practice.

Updates in the Management of Relapsing Multiple Sclerosis

December 10th 2020

Fred Lublin, MD; Patricia K. Coyle, MD; Mark Freedman, MD; and Scott D. Newsome, DO, discuss a number of topics pertaining to the diagnosis of multiple sclerosis, including a focus on fatigue and its impact on quality of life.

Advances in the Management of Acute Treatment of Migraine

October 28th 2020

Global Approaches to the Management of Relapsing Multiple Sclerosis

September 3rd 2020

Management of Cardiac Amyloidosis

April 30th 2020